A new painkiller has been approved for sale. This medication, Journavx, is a step forward that skips those addictive opioids that many of us are familiar with. Think of it as a shortcut around the addiction crisis.  This pain reliever tackles those intense, short-term pains from things like surgery, but it won’t give you that "high" addiction that opioids are known for. So that's a win for patients.

    Tossed into the mix of treatments for moderate to extreme pain. 80 million American folks are given meds for these pains.  It's a good idea to avoid those opioid responses.  For decades, doctors have been throwing some type of drugs that bring on a high to ease pain it makes it addictive. Now they can simply give this drug to treat short-term discomforts safely.

    Opioids can activate brain receptors. This reduces the capacity to experience pain, but it can also result in a euphoric state, making them habit-forming and addictive.  Checkmates and defeats the odds for addiction, Journavx gets into the business of blocking nerve pain signals in the body.  Shocking. No addictive potential and no brain attachment – that is a game changer.

    A total of 874 individuals who were facing some intense pain from surgery participated in the trials of Journavx. Participants in the trials did not know who was getting the actual medicine or who was getting a substitute, and neither the doctors nor the researchers knew who was getting what. Moreover, they also had ibuprofen as an option, which works by interfering with enzymes responsible for pain and inflammation.

    The patients who received Journavx reported a significant reduction in pain. The company behind the research noted that temporary side effects. Read: temporary fertility reduction and it can also increase muscle spasms creatine, and a rash. In the mood for more? It also hampers female fertility. Female patients worried about this or experiencing it should chat with their healthcare team before taking the medication.

    It is now accessible to people only that are adults. This is because it is not yet clear whether it would be safe and effective for kids, too.   The FDA gives it a thumbs up. A non-addictive pain reliever that could come in handy against a world of painkillers.

Ending the Opioid Addictionwith New Journavx Drug

Actions